These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 36924900)

  • 1. Investigate the immunogenic and protective effect of trivalent chimeric protein containing IpaD-StxB-TolC antigens as a vaccine candidate against S. dysenteri and S. flexneri.
    Fathi J; Amani J; Nazarian S; Hadi N; Mirhosseini SA; Ranjbar R; Abianeh HS
    Microb Pathog; 2023 May; 178():106066. PubMed ID: 36924900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An approach to chimeric subunit immunogen provides efficient protection against toxicity, type III and type v secretion systems of Shigella.
    Felegary A; Nazarian S; Kordbacheh E; Fathi J; Minae ME
    Int Immunopharmacol; 2021 Nov; 100():108132. PubMed ID: 34508943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenic Potency of a Chimeric Protein Comprising InvH and IpaD against Salmonella and Shigella spp.
    Emami Mahmoudabadi FS; Vakili A; Nazarian S; Amani J; Mousavi Gargari SL
    Iran J Allergy Asthma Immunol; 2021 Aug; 20(4):484-493. PubMed ID: 34418902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A broadly immunogenic polyvalent
    Li S; Anvari S; Ptacek G; Upadhyay I; Kaminski RW; Sack DA; Zhang W
    Infect Immun; 2023 Nov; 91(11):e0031623. PubMed ID: 37795982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of egg yolk antibody (IgY) against a chimeric protein containing IpaD, StxB, and TolC antigens from Shigella: An investigation of its prophylactic effects against Shiga toxin (Stx) and
    Hadi N; Nazarian S; Rouhi S; Hosseini SE; Fathi J
    Heliyon; 2024 Feb; 10(4):e26361. PubMed ID: 38404796
    [No Abstract]   [Full Text] [Related]  

  • 6. Expression and purification of TolC as a recombinant protein vaccine against Shigella flexneri and evaluation of immunogenic response in mice.
    Veisi R; Nazarian S; Fathi J; Hadi N
    Microb Pathog; 2024 Mar; 188():106539. PubMed ID: 38211835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards a vaccine candidate against Shigella dysenteriae 1: expression of the Shiga toxin B-subunit in an attenuated Shigella flexneri aroD carrier strain.
    Tzschaschel BD; Klee SR; de Lorenzo V; Timmis KN; Guzmán CA
    Microb Pathog; 1996 Oct; 21(4):277-88. PubMed ID: 8905616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An
    Fathi J; Nazarian S; Kordbacheh E; Hadi N
    Avicenna J Med Biotechnol; 2022; 14(3):247-258. PubMed ID: 36061128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterologous expression of Intimin and IpaB fusion protein in Lactococcus lactis and its mucosal delivery elicit protection against pathogenicity of Escherichia coli O157 and Shigella flexneri in a murine model.
    Sagi S; Konduru B; Parida M
    Int Immunopharmacol; 2020 Aug; 85():106617. PubMed ID: 32464569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of recombinant vaccine candidate molecule against Shigella infection.
    Chitradevi STS; Kaur G; Sivaramakrishna U; Singh D; Bansal A
    Vaccine; 2016 Oct; 34(44):5376-5383. PubMed ID: 27591952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization against Vibrio cholerae, ETEC, and EHEC with chitosan nanoparticle containing LSC chimeric protein.
    Ghaffari Marandi BH; Zolfaghari MR; Kazemi R; Motamedi MJ; Amani J
    Microb Pathog; 2019 Sep; 134():103600. PubMed ID: 31202906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective immunization against Enterohemorrhagic Escherichia coli and Shigella dysenteriae Type 1 by chitosan nanoparticle loaded with recombinant chimeric antigens comprising EIT and STX1B-IpaD.
    Mosadegh S; Abtahi H; Amani J; Karizi SZ; Salmanian AH
    Microb Pathog; 2023 Nov; 184():106344. PubMed ID: 37704060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a novel fusion protein from IpaB and IpaD of Shigella spp. and its potential as a pan-Shigella vaccine.
    Martinez-Becerra FJ; Chen X; Dickenson NE; Choudhari SP; Harrison K; Clements JD; Picking WD; Van De Verg LL; Walker RI; Picking WL
    Infect Immun; 2013 Dec; 81(12):4470-7. PubMed ID: 24060976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of immunogenicity and protective efficacy of orally delivered Shigella type III secretion system proteins IpaB and IpaD.
    Heine SJ; Diaz-McNair J; Martinez-Becerra FJ; Choudhari SP; Clements JD; Picking WL; Pasetti MF
    Vaccine; 2013 Jun; 31(28):2919-29. PubMed ID: 23644075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Broadly protective Shigella vaccine based on type III secretion apparatus proteins.
    Martinez-Becerra FJ; Kissmann JM; Diaz-McNair J; Choudhari SP; Quick AM; Mellado-Sanchez G; Clements JD; Pasetti MF; Picking WL
    Infect Immun; 2012 Mar; 80(3):1222-31. PubMed ID: 22202122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-administration of rIpaB domain of Shigella with rGroEL of S. Typhi enhances the immune responses and protective efficacy against Shigella infection.
    Chitradevi ST; Kaur G; Uppalapati S; Yadav A; Singh D; Bansal A
    Cell Mol Immunol; 2015 Nov; 12(6):757-67. PubMed ID: 25640657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Live attenuated Shigella dysenteriae type 1 vaccine strains overexpressing shiga toxin B subunit.
    Wu T; Grassel C; Levine MM; Barry EM
    Infect Immun; 2011 Dec; 79(12):4912-22. PubMed ID: 21969003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Designing and evaluation of an antibody-targeted chimeric recombinant vaccine encoding Shigella flexneri outer membrane antigens.
    Kazi A; Hisyam Ismail CMK; Anthony AA; Chuah C; Leow CH; Lim BH; Banga Singh KK; Leow CY
    Infect Genet Evol; 2020 Jun; 80():104176. PubMed ID: 31923724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Designing and Expression of Recombinant Chimeric Protein Containing CtxB and OmpW from Vibrio Cholerae and Evaluation of Its Immunogenicity.
    Vakili A; Mousavi Gargari SL; Nazarian S; Amani J
    Iran J Immunol; 2018 Sep; 15(3):207-220. PubMed ID: 30246696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IpaD-loaded N-trimethyl Chitosan Nanoparticles Can Efficiently Protect Guinea Pigs against Shigella flexneri.
    Akbari MR; Saadati M; Honari H; Ghorbani HM
    Iran J Immunol; 2019 Sep; 16(3):212-224. PubMed ID: 31552830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.